News
10-28-2015, 10:26 PM
The U.S. Food and Drug Administration announced on Oct. 27 that it has approved, for the first time, an oncolytic (cancer-killing) viral therapy in the United States. The drug was approved for use against late-stage melanoma, a deadly skin cancer that can be difficult to treat.
More... (http://www.news-medical.net/news/20151029/Oncolytic-(cancer-killing)-viral-therapy-approved-in-the-US-for-use-against-late-stage-melanoma.aspx)
More... (http://www.news-medical.net/news/20151029/Oncolytic-(cancer-killing)-viral-therapy-approved-in-the-US-for-use-against-late-stage-melanoma.aspx)